GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries
Barbara Engelhardt moves her computational and statistics lab to Gladstone
The trial will be conducted across 10 sites in India
Subscribe To Our Newsletter & Stay Updated
